Market Tracker

12/09 5:16pm ET

NewLink Genetics Corp (NASDAQ:NLNK)

11.14
Delayed Data
As of Dec 09
 +0.13 / +1.18%
Today’s Change
9.23
Today|||52-Week Range
37.65
-69.39%
Year-to-Date
Inovio Pharmaceuticals, Inc.'s Biggest Win in 2016
Dec 09 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close11.01
Today’s open11.13
Day’s range11.04 - 11.47
Volume173,611
Average volume (3 months)285,736
Market cap$324.6M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-142.47%
Earnings growth (this year)-119.15%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.31%
P/E ratioNM
Price/Sales15.19
Price/Book1.64

Competitors

 Today’s
change
Today’s
% change
ARLZAralez Pharmaceutica...+0.14+2.83%
AKBAAkebia Therapeutics ...+0.05+0.59%
SRNESorrento Therapeutic...-0.05-0.92%
MNKDMannKind Corp-0.00-0.09%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$68.5M
Annual profit (last year)-$40.4M
Net profit margin-58.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President, Director &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts